Skip to main content
Log in

CYP1B1 (4326C > G), CYP2F1 (c.14_15insC), CYP2J2 (−76G > T), and CYP2S1 (13106C > T and 13255A > G) polymorphisms and genetic predisposition to chronic respiratory diseases induced by smoking and occupational factors

  • Human Genetics
  • Published:
Russian Journal of Genetics Aims and scope Submit manuscript

Abstract

The contribution of the polymorphic markers of cytochrome P450 genes to respiratory diseases caused by smoking and occupational factors has been assessed. For this purpose, PCR-RFLP analysis of the CYP1B1 (rs1056836, 4326C > G), CYP2F1 (rs11399890, c.14_15insC), CYP2J2 (rs890293, -76G > T), and CYP2S1 (rs34971233, 13106C > T and rs338583, 13255A > G) gene polymorphisms has been performed. The analysis has shown that CYP1B1 (rs1056836, 4326C > G) and CYP2F1 (rs11399890, c.14_15insC) polymorphisms may contribute to the development of occupational chronic bronchitis. The proportion of CYP1B1*1*3 heterozygotes in the group of patients with occupational chronic bronchitis is considerably greater than in the group of healthy workers (69.16% versus 53.29%; χ2 = 5.94, p = 0.02, p cur = 0.04, OR = 1.97, the 95% CI is 1.13–3.42). Patients with occupational chronic bronchitis and healthy workers significantly differed from each other in the CYP2F1 genotypes frequency distribution (rs11399890, c.14_15insC) (χ2 = 6.18, d.f. = 2, p = 0.05). CYP2F1 wild type/ins heterozygous genotype frequency is higher in healthy workers (36.08%) than in patients (22.22%) (χ2 = 5.48, p = 0.02, p cur = 0.04, OR = 0.51, the 95% CI is 0.28–0.90). No association has been found between the CYP2J2 (rs890293, −76G > T) or CYP2S1 (rs34971233, 13106C > T, and rs338583, 13255A > G) gene polymorphisms and respiratory diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. GOLD Workshop Report: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Updated 2009, www.goldcopd.com.

  2. Chuchalin, A.G., Khronicheskie obstruktivnye bolezni legkikh (Chronic Obstructive Pulmonary Disease), Moscow: BINOM, 1999.

    Google Scholar 

  3. Gichev, Yu.P., Zagryaznenie okruzhayushchei sredy i zdorov’e cheloveka (Pechal’nyi opyt Rossii) (Environmental Pollution and the Human Health (Unhappy Experience of Russia)), Novosibirsk: Sibirskoye Otdelenie Ross. Akad. Med. Nauk, 2002.

    Google Scholar 

  4. Spitsyn, V.A., Ekologicheskaya genetika cheloveka (Ecological Human Genetics), Moscow: Nauka, 2008.

    Google Scholar 

  5. Hukkanen, J., Xenobiotic-Metabolizing Cytochrome P450 Enzymes in Human Lung, http://herkules.oulu.fi/isbn9514258649/.

  6. Ingelman-Sundberg, M., Human Drug Metabolising Cytochrome P450 Enzymes: Properties and Polymorphism, Naunyn Schmiedebergs Arch. Pharmacol., 2004, vol. 369, no. 1, pp.89–104.

    Article  PubMed  CAS  Google Scholar 

  7. Nelson, D.R., The Cytochrome P450 Homepage, Hum. Genomics, 2009, vol. 4, no. 1, pp. 59–65.

    PubMed  CAS  Google Scholar 

  8. Rodriguez-Antona, C., Gomez, A., Karlgren, M., et al., Molecular Genetics and Epigenetics of the Cytochrome P450 Gene Family and Its Relevance for Cancer Risk and Treatment, Hum. Genet., 2010, vol. 127, no. 1, pp. 1–17.

    Article  PubMed  CAS  Google Scholar 

  9. Goodman, M.T., McDuffie, K., Kolonel, L.N., et al., Case-Control Study of Ovarian Cancer and Polymorphisms in Genes Involved in Catecholestrogen Formation and Metabolism, Cancer Epidemiol. Biomarkers Prev., 2001, vol. 10, no. 3, pp. 209–216.

    PubMed  CAS  Google Scholar 

  10. Saarikoski, S.T., Suitiala, T., Holmila, R., et al., Identification of Genetic Polymorphisms of CYP2S1 in a Finnish Caucasian Population, Mutat. Res., 2004, vol. 554, nos. 1–2, pp. 267–277.

    PubMed  CAS  Google Scholar 

  11. Spiecker, M., Darius, H., Hankeln, T., et al., Risk of Coronary Artery Disease Associated with Polymorphism of the Cytochrome P450 Epoxygenase CYP2J2, Circulation, 2004, vol. 110, no. 15, pp. 2132–2136.

    Article  PubMed  CAS  Google Scholar 

  12. Tournel, G., Cauffiez, C., Billaut Laden, I., et al., Molecular Analysis of the CYP2F1 Gene: Identification of a Frequent Non Functional Allelic Variant, Mutat. Res., 2007, vol. 617, nos. 1–2, pp. 79–89.

    PubMed  CAS  Google Scholar 

  13. Tournel, G., Cauffiez, C., Leclerc, J., et al., CYP2F1 Genetic Polymorphism: Identification of Interethnic Variations, Chem. Unserer Zeit, 2007, vol. 37, p. 1433.

    CAS  Google Scholar 

  14. Glanz, S.A., BIOSTATISTICA, Primer of Biostatistics Version 4.03, McGraw Hill, 1998.

  15. Korytina, G.F., Akhmadishina, L.Z., and Viktorova, T.V., The Frequencies of Polymorphic Variants of the CYP1F1 and CYP2F1 Genes in Three Ethnic Groups of the Republic of Bashkortostan and in Patients with Chronic Obstructive Pulmonary Disease, Mol. Biol. (Moscow), 2010, vol. 44, no. 1, pp. 33–41.

    Article  CAS  Google Scholar 

  16. Polonikov, A.V., Ivanov, V.P., and Solodilova, M.A., Genetic Variation of Genes for Xenobiotic-Metabolizing Enzymes and Risk of Bronchial Asthma: The Importance of Gene-Gene and Gene-Environment Interactions for Disease Susceptibility, J. Hum. Genet., 2009, vol. 54, no. 8, pp. 440–9.

    Article  PubMed  CAS  Google Scholar 

  17. Timofeeva, M.N., Kropp, S., Sauter, W., et al., CYP450 Polymorphisms as Risk Factors for Early-Onset Lung Cancer: Gender-Specific Differences, Carcinogenesis, 2009, vol. 30, no. 7, pp. 1161–1169.

    Article  PubMed  CAS  Google Scholar 

  18. Baldwin, R.M., Jewell, W.T., Fanucchi, M.V., et al., Comparison of Pulmonary/Nasal CYP2F Expression Levels in Rodents and Rhesus Macaque, J. Pharmacol. Exp. Ther., 2004, vol. 309, p. 127.

  19. Polonikov, A.V., Ivanov, V.P., Solodilova, M.A., et al., Promoter Polymorphism G-50T of a Human CYP2J2 Epoxygenase Gene Is Associated with Common Susceptibility to Asthma, Chest, 2007, vol. 132, no. 1, pp. 120–126.

    Article  PubMed  CAS  Google Scholar 

  20. Kumarakulasingham, M., Rooney, P.H., Dundas, S.R., et al., Cytochrome P450 Profile of Colorectal Cancer: Identification of Markers of Prognosis, Clin. Cancer Res., 2005, vol. 11, no. 10, pp. 3758–3765.

    Article  PubMed  CAS  Google Scholar 

  21. Downie, D., McFadyen, M.C., Rooney, P.H., et al., Profiling Cytochrome P450 Expression in Ovarian Cancer: Identification of Prognostic Markers, Clin. Cancer Res., 2005, vol. 11, no. 20, pp. 7369–7375.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L. Z. Akhmadishina.

Additional information

Original Russian Text © L.Z. Akhmadishina, G.F. Korytina, T.V. Victorova, 2011, published in Genetika, 2011, Vol. 47, No.10, pp. 1402–1410.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Akhmadishina, L.Z., Korytina, G.F. & Victorova, T.V. CYP1B1 (4326C > G), CYP2F1 (c.14_15insC), CYP2J2 (−76G > T), and CYP2S1 (13106C > T and 13255A > G) polymorphisms and genetic predisposition to chronic respiratory diseases induced by smoking and occupational factors. Russ J Genet 47, 1248–1255 (2011). https://doi.org/10.1134/S102279541109002X

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S102279541109002X

Keywords

Navigation